Document is current
Any future updates will be listed below
-
Authors
O’Connell, James https://orcid.org/0000-0002-3138-8074
Porter, John https://orcid.org/0000-0002-5915-1546
Kroeplien, Boris https://orcid.org/0000-0003-2346-162X
Norman, Tim
Rapecki, Stephen
Davis, Rachel
McMillan, David https://orcid.org/0000-0001-9376-0284
Arakaki, Tracy
Burgin, Alex
Fox III, David
Ceska, Tom
Lecomte, Fabien
Maloney, Alison
Vugler, Alex
Carrington, Bruce
Cossins, Benjamin P
Bourne, Tim
Lawson, Alastair
- License Information
-
More Information
Article History
Received: 10 April 2019
Accepted: 14 November 2019
First Online: 19 December 2019
Competing interests
: J.O.’C., J.P., B.K., T.N., S.R., R.D., D.McM., D.F., T.C., F.L., A.M., A.V., B.C., B.Co., T.B. and A.L. are/were all employees of UCB Pharma and may hold stock and/or stock options. T.A. and A.B. declare no competing interests.
